I assume that any DS lani production/distribution proposal would be considered as would those from GSK, Roche and others. If DS is actually manufacturing lani, I am sure they would want to make more.
Any lani hopefull probably have a war-chest sufficient to gobble up BTA. Imagine GSK, Roche & DS first fighting for lani and then 5 minutes later battling for control or complete take-over of Biota!
In my thread "biota's future" and others I have expressed my concern re low sp and takeover risk. I have the impression that GSK will be "watching our back". The ways that I think that could be done are: * GSK take a chunk of predator, forcing it's defence? * GSK take a friendly chunk of Biota? * GSK pay royalty early so BTA can pay a large dividend?
The risk could be that a GSK friendly chunk of biota might actually turn them into the predator.
I also feel that any company like Biota would have anti-takever preparations. A previous thread included a list of these possibilities.
Sorry, that is a little bit off the subject, but it seems a logical progression.
DYOR
BTA Price at posting:
$2.06 Sentiment: Hold Disclosure: Held
